This NIH R13 grant supports an annual intensive workshop or conference for early-stage HIV/AIDS researchers. The primary goal is to guide those utilizing nonhuman primate (NHP) models in translating their preclinical findings to human clinical trials. Topics covered include developing strategies to reduce HIV/AIDS incidence, such as vaccine development, next-generation and cure therapies, and prevention. The conference also addresses treatment of associated coinfections and complications. Beyond scientific translation, the program focuses on developing essential career skills like networking, grantsmanship, and managing goal-driven projects. Attendees will also learn about statistical and host genetics considerations and methods for effectively translating NHP study results to human clinical settings, fostering new NHP research programs that mirror clinical observations.
Opportunity ID: 345693
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-262 |
| Funding Opportunity Title: | Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.351 — Research Infrastructure Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 31, 2023 |
| Last Updated Date: | Jan 31, 2023 |
| Original Closing Date for Applications: | Jan 07, 2024 |
| Current Closing Date for Applications: | Jan 07, 2024 |
| Archive Date: | Feb 12, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $75,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education State governments For profit organizations other than small businesses City or township governments Small businesses County governments Native American tribal governments (Federally recognized) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-22-262.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 345693 Full Announcement-PAR-22-262 -> PAR-22-262-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00279583 | Apr 07, 2023 | Jan 07, 2024 | View |
Package 1
Mandatory forms
345693 RR_SF424_5_0-5.0.pdf
345693 PHS398_CoverPageSupplement_5_0-5.0.pdf
345693 RR_OtherProjectInfo_1_4-1.4.pdf
345693 PerformanceSite_4_0-4.0.pdf
345693 RR_KeyPersonExpanded_4_0-4.0.pdf
345693 RR_Budget_3_0-3.0.pdf
345693 PHS398_ResearchPlan_5_0-5.0.pdf
345693 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345693 RR_SubawardBudget30_3_0-3.0.pdf
345693 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
